Global Recombinant Therapeutic Protein Market Insights and Forecast to 2028

Global Recombinant Therapeutic Protein Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Recombinant Therapeutic Protein Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Human Collage
1.2.3 Recombinant Human Serum Albumin
1.3 Market by Application
1.3.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medicine
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Therapeutic Protein Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Therapeutic Protein Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Therapeutic Protein Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Therapeutic Protein Sales by Region
2.4.1 Global Recombinant Therapeutic Protein Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Therapeutic Protein by Region (2023-2028)
2.5 Global Recombinant Therapeutic Protein Revenue by Region
2.5.1 Global Recombinant Therapeutic Protein Revenue by Region (2017-2022)
2.5.2 Global Recombinant Therapeutic Protein Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Therapeutic Protein Sales by Manufacturers
3.1.1 Global Top Recombinant Therapeutic Protein Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Therapeutic Protein in 2021
3.2 Global Recombinant Therapeutic Protein Revenue by Manufacturers
3.2.1 Global Recombinant Therapeutic Protein Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Therapeutic Protein Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Therapeutic Protein Revenue in 2021
3.3 Global Recombinant Therapeutic Protein Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Therapeutic Protein Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Therapeutic Protein Sales by Type
4.1.1 Global Recombinant Therapeutic Protein Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Therapeutic Protein Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Therapeutic Protein Revenue by Type
4.2.1 Global Recombinant Therapeutic Protein Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Therapeutic Protein Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Therapeutic Protein Price by Type
4.3.1 Global Recombinant Therapeutic Protein Price by Type (2017-2022)
4.3.2 Global Recombinant Therapeutic Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Therapeutic Protein Sales by Application
5.1.1 Global Recombinant Therapeutic Protein Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Therapeutic Protein Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Therapeutic Protein Revenue by Application
5.2.1 Global Recombinant Therapeutic Protein Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Therapeutic Protein Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Therapeutic Protein Price by Application
5.3.1 Global Recombinant Therapeutic Protein Price by Application (2017-2022)
5.3.2 Global Recombinant Therapeutic Protein Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Therapeutic Protein Market Size by Type
6.1.1 North America Recombinant Therapeutic Protein Sales by Type (2017-2028)
6.1.2 North America Recombinant Therapeutic Protein Revenue by Type (2017-2028)
6.2 North America Recombinant Therapeutic Protein Market Size by Application
6.2.1 North America Recombinant Therapeutic Protein Sales by Application (2017-2028)
6.2.2 North America Recombinant Therapeutic Protein Revenue by Application (2017-2028)
6.3 North America Recombinant Therapeutic Protein Market Size by Country
6.3.1 North America Recombinant Therapeutic Protein Sales by Country (2017-2028)
6.3.2 North America Recombinant Therapeutic Protein Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Therapeutic Protein Market Size by Type
7.1.1 Europe Recombinant Therapeutic Protein Sales by Type (2017-2028)
7.1.2 Europe Recombinant Therapeutic Protein Revenue by Type (2017-2028)
7.2 Europe Recombinant Therapeutic Protein Market Size by Application
7.2.1 Europe Recombinant Therapeutic Protein Sales by Application (2017-2028)
7.2.2 Europe Recombinant Therapeutic Protein Revenue by Application (2017-2028)
7.3 Europe Recombinant Therapeutic Protein Market Size by Country
7.3.1 Europe Recombinant Therapeutic Protein Sales by Country (2017-2028)
7.3.2 Europe Recombinant Therapeutic Protein Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Therapeutic Protein Market Size by Type
8.1.1 Asia Pacific Recombinant Therapeutic Protein Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Therapeutic Protein Market Size by Application
8.2.1 Asia Pacific Recombinant Therapeutic Protein Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Therapeutic Protein Market Size by Region
8.3.1 Asia Pacific Recombinant Therapeutic Protein Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Therapeutic Protein Market Size by Type
9.1.1 Latin America Recombinant Therapeutic Protein Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Therapeutic Protein Revenue by Type (2017-2028)
9.2 Latin America Recombinant Therapeutic Protein Market Size by Application
9.2.1 Latin America Recombinant Therapeutic Protein Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Therapeutic Protein Revenue by Application (2017-2028)
9.3 Latin America Recombinant Therapeutic Protein Market Size by Country
9.3.1 Latin America Recombinant Therapeutic Protein Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Therapeutic Protein Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Therapeutic Protein Market Size by Type
10.1.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Therapeutic Protein Market Size by Application
10.2.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Therapeutic Protein Market Size by Country
10.3.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Celldex Therapeutics
11.3.1 Celldex Therapeutics Corporation Information
11.3.2 Celldex Therapeutics Overview
11.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celldex Therapeutics Recent Developments
11.4 Eli Liily
11.4.1 Eli Liily Corporation Information
11.4.2 Eli Liily Overview
11.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Liily Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Liily Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Overview
11.6.3 Merck Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Corporation Information
11.8.2 Regeneron Pharmaceuticals Overview
11.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Regeneron Pharmaceuticals Recent Developments
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Overview
11.9.3 Roche Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Roche Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Roche Recent Developments
11.10 Takeda
11.10.1 Takeda Corporation Information
11.10.2 Takeda Overview
11.10.3 Takeda Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Therapeutic Protein Industry Chain Analysis
12.2 Recombinant Therapeutic Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Therapeutic Protein Production Mode & Process
12.4 Recombinant Therapeutic Protein Sales and Marketing
12.4.1 Recombinant Therapeutic Protein Sales Channels
12.4.2 Recombinant Therapeutic Protein Distributors
12.5 Recombinant Therapeutic Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Therapeutic Protein Industry Trends
13.2 Recombinant Therapeutic Protein Market Drivers
13.3 Recombinant Therapeutic Protein Market Challenges
13.4 Recombinant Therapeutic Protein Market Restraints
14 Key Findings in The Global Recombinant Therapeutic Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Recombinant Therapeutic Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Recombinant Human Collage
Table 3. Major Manufacturers of Recombinant Human Serum Albumin
Table 4. Global Recombinant Therapeutic Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Recombinant Therapeutic Protein Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Recombinant Therapeutic Protein Sales by Region (2017-2022) & (MT)
Table 7. Global Recombinant Therapeutic Protein Sales Market Share by Region (2017-2022)
Table 8. Global Recombinant Therapeutic Protein Sales by Region (2023-2028) & (MT)
Table 9. Global Recombinant Therapeutic Protein Sales Market Share by Region (2023-2028)
Table 10. Global Recombinant Therapeutic Protein Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2017-2022)
Table 12. Global Recombinant Therapeutic Protein Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2023-2028)
Table 14. Global Recombinant Therapeutic Protein Sales by Manufacturers (2017-2022) & (MT)
Table 15. Global Recombinant Therapeutic Protein Sales Share by Manufacturers (2017-2022)
Table 16. Global Recombinant Therapeutic Protein Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Recombinant Therapeutic Protein Revenue Share by Manufacturers (2017-2022)
Table 18. Recombinant Therapeutic Protein Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Recombinant Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Therapeutic Protein as of 2021)
Table 21. Recombinant Therapeutic Protein Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Recombinant Therapeutic Protein Product Offered
Table 23. Date of Manufacturers Enter into Recombinant Therapeutic Protein Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
Table 26. Global Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
Table 27. Global Recombinant Therapeutic Protein Sales Share by Type (2017-2022)
Table 28. Global Recombinant Therapeutic Protein Sales Share by Type (2023-2028)
Table 29. Global Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Recombinant Therapeutic Protein Revenue Share by Type (2017-2022)
Table 32. Global Recombinant Therapeutic Protein Revenue Share by Type (2023-2028)
Table 33. Recombinant Therapeutic Protein Price by Type (2017-2022) & (USD/MT)
Table 34. Global Recombinant Therapeutic Protein Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
Table 36. Global Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
Table 37. Global Recombinant Therapeutic Protein Sales Share by Application (2017-2022)
Table 38. Global Recombinant Therapeutic Protein Sales Share by Application (2023-2028)
Table 39. Global Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Recombinant Therapeutic Protein Revenue Share by Application (2017-2022)
Table 42. Global Recombinant Therapeutic Protein Revenue Share by Application (2023-2028)
Table 43. Recombinant Therapeutic Protein Price by Application (2017-2022) & (USD/MT)
Table 44. Global Recombinant Therapeutic Protein Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
Table 46. North America Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
Table 47. North America Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
Table 50. North America Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
Table 51. North America Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
Table 54. North America Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
Table 55. North America Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
Table 58. Europe Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
Table 59. Europe Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
Table 62. Europe Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
Table 63. Europe Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
Table 66. Europe Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
Table 67. Europe Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
Table 70. Asia Pacific Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
Table 71. Asia Pacific Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
Table 74. Asia Pacific Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
Table 75. Asia Pacific Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2017-2022) & (MT)
Table 78. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2023-2028) & (MT)
Table 79. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
Table 82. Latin America Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
Table 83. Latin America Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
Table 86. Latin America Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
Table 87. Latin America Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
Table 90. Latin America Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
Table 91. Latin America Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
Table 94. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
Table 95. Middle East and Africa Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
Table 98. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
Table 99. Middle East and Africa Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
Table 102. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
Table 103. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Major Businesses
Table 107. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Boehringer Ingelheim Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Boehringer Ingelheim Recent Developments
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Major Businesses
Table 112. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Bristol-Myers Squibb Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bristol-Myers Squibb Recent Developments
Table 115. Celldex Therapeutics Corporation Information
Table 116. Celldex Therapeutics Description and Major Businesses
Table 117. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Celldex Therapeutics Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Celldex Therapeutics Recent Developments
Table 120. Eli Liily Corporation Information
Table 121. Eli Liily Description and Major Businesses
Table 122. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Eli Liily Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Liily Recent Developments
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Major Businesses
Table 127. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. GlaxoSmithKline Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GlaxoSmithKline Recent Developments
Table 130. Merck Corporation Information
Table 131. Merck Description and Major Businesses
Table 132. Merck Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Merck Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Merck Recent Developments
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Major Businesses
Table 137. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Novartis Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Novartis Recent Developments
Table 140. Regeneron Pharmaceuticals Corporation Information
Table 141. Regeneron Pharmaceuticals Description and Major Businesses
Table 142. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Regeneron Pharmaceuticals Recent Developments
Table 145. Roche Corporation Information
Table 146. Roche Description and Major Businesses
Table 147. Roche Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Roche Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Roche Recent Developments
Table 150. Takeda Corporation Information
Table 151. Takeda Description and Major Businesses
Table 152. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Takeda Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Takeda Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Recombinant Therapeutic Protein Distributors List
Table 158. Recombinant Therapeutic Protein Customers List
Table 159. Recombinant Therapeutic Protein Market Trends
Table 160. Recombinant Therapeutic Protein Market Drivers
Table 161. Recombinant Therapeutic Protein Market Challenges
Table 162. Recombinant Therapeutic Protein Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Therapeutic Protein Product Picture
Figure 3. Global Recombinant Therapeutic Protein Market Share by Type in 2021 & 2028
Figure 3. Recombinant Human Collage Product Picture
Figure 4. Recombinant Human Serum Albumin Product Picture
Figure 5. Global Recombinant Therapeutic Protein Market Share by Application in 2021 & 2028
Figure 6. Medicine
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Recombinant Therapeutic Protein Report Years Considered
Figure 10. Global Recombinant Therapeutic Protein Sales 2017-2028 (MT)
Figure 11. Global Recombinant Therapeutic Protein Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Recombinant Therapeutic Protein Revenue 2017-2028 (US$ Million)
Figure 13. Global Recombinant Therapeutic Protein Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Recombinant Therapeutic Protein Sales Market Share by Region (2017-2022)
Figure 15. Global Recombinant Therapeutic Protein Sales Market Share by Region (2023-2028)
Figure 16. North America Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
Figure 17. North America Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
Figure 19. Europe Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
Figure 21. Asia-Pacific Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
Figure 23. Latin America Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
Figure 25. Middle East & Africa Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Recombinant Therapeutic Protein Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Recombinant Therapeutic Protein in the World: Market Share by Recombinant Therapeutic Protein Revenue in 2021
Figure 28. Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
Figure 30. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
Figure 31. Global Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
Figure 32. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
Figure 33. North America Recombinant Therapeutic Protein Sales M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs